Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Preferred Shares: 2012-2013

  • Agios Pharmaceuticals' Preferred Shares was N/A to $5.7 million in Q3 2013 from the same period last year, while for Sep 2013 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $77.3 million for FY2012, which is N/A change from last year.
  • Agios Pharmaceuticals' Preferred Shares amounted to $5.7 million in Q3 2013, which was down 92.63% from $77.3 million recorded in Q2 2013.
  • Agios Pharmaceuticals' Preferred Shares' 5-year high stood at $77.3 million during Q4 2012, with a 5-year trough of $5.7 million in Q3 2013.
  • Its 2-year average for Preferred Shares is $53.4 million, with a median of $77.3 million in 2013.